The groups argued against expanding monopolies that would thwart generic competition; rules that would restrict government rights to control prices; and maintaining so-called investor-state disputes which, under international trade treaties, allow companies to initiate claims against foreign governments.
from Kaiser Health News http://ift.tt/2GiKY2G
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment